- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- Public filings
- Bulk ZIP download
- Dashboard access (1 year)
Key Metrics
Company Health Scores
Health scores for Sun Pharma Laboratories Limited covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
About Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN U25200GJ1997PLC133846). Business overview includes Pharma (Drug Formulation & Development), incorporated on January 17, 1997 (29+ years old), headquartered in Vadodara, Gujarat, India. The company is currently Active with Active Compliant compliance status. For FY 2024, the company reported revenue of ₹12.71 Kharab with a profit of ₹4.73 Kharab. It has 9 active directors. The company employs approximately 1,968 people. Its latest credit rating is A1 by Icra.
- Location Sun Pharma Advanced Research Centre (Sparc), Tandalja,, Vadodara, Gujarat - 390012
- Website sunpharma.com
Financial Performance of Sun Pharma Laboratories Limited
| Metrics | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,20,083.04 cr | 2,35,431.21 cr | 2,51,890.00 cr | 2,18,400.00 cr | 1,95,200.00 cr | 1,72,000.00 cr | 1,59,000.00 cr |
| Profit/Loss | 13,969.70 cr | 4,810.00 cr | 12,200.00 cr | 9,100.00 cr | -8,200.00 cr | 3,200.00 cr | 5,100.00 cr |
| Cash & Bank Balance | 38,200.00 cr | 35,100.00 cr | 32,000.00 cr | 28,500.00 cr | 25,200.00 cr | 22,000.00 cr | 19,800.00 cr |
| Net Worth | 1,26,731.94 cr | 1,37,500.00 cr | 1,40,200.00 cr | 1,28,000.00 cr | 1,15,000.00 cr | 1,02,000.00 cr | 95,000.00 cr |
| EBITDA | 27,865.49 cr | 29,800.00 cr | 30,200.00 cr | 27,000.00 cr | 24,500.00 cr | 22,000.00 cr | 20,100.00 cr |
Financial Ratios
Values in Crores (Cr) - illustrative trend
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Profit Margin | 10.54 | 3.20 | 2.10 | 1.80 | 0.50 |
| Debt to EBITDA | 2.14 | 1.90 | 1.70 | 1.50 | 1.20 |
| Interest Coverage Ratio | 0.47 | 0.50 | 0.45 | 0.40 | 0.35 |
| Debt to Equity | 0.88 | 0.90 | 0.85 | 0.80 | 0.75 |
| Return on Equity | 12.10 | 3.00 | 2.00 | 1.50 | 0.20 |
| Current Ratio | 1.20 | 1.15 | 1.10 | 1.05 | 0.99 |
| Quick Ratio | 0.95 | 0.92 | 0.88 | 0.85 | 0.80 |
| EBITDA Margin | 12.00 | 10.00 | 8.00 | 7.00 | 5.00 |
| Return on Capital Employed | 8.00 | 2.00 | 1.00 | 0.20 | 0.00 |
| Earning Per Share | 4.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPFO Establishments (1)
Current Directors (9)
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Electricity, gas, steam and air condition supply | - | 0.44 |
| Manufacturing | - | 99.56 |
Flagged By Authority
Regulatory and exchange flags (preview)
Legal Cases
- Priti Paras Savla
- Meetal Sharad Sampat
- Rakeshchandra Jagdishprasad Sinha
- Kirti Wardhaman Ganorkar
- Chinnadharavaram Sundaresan Muralidharan
- Jayashree Satagopan
- Gautam Bhailal Doshi
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.